Publication: How Does Vaccination against SARS-CoV-2 Affect Hospitalized Patients with COVID-19?
dc.contributor.author | Moreno-Nunez, Paloma | |
dc.contributor.author | Bueno-Cavanillas, Aurora | |
dc.contributor.author | San Jose-Saras, Diego | |
dc.contributor.author | Vicente-Guijarro, Jorge | |
dc.contributor.author | Fernandez Chavez, Abelardo Claudio | |
dc.contributor.author | Aranaz-Andres, Jesus Maria | |
dc.contributor.group | On Behalf Of Health Outcomes Research Group Of The Instituto Ramón Y Cajal de Investigación Sanitaria Irycis, | |
dc.date.accessioned | 2023-05-03T14:08:24Z | |
dc.date.available | 2023-05-03T14:08:24Z | |
dc.date.issued | 2022-07-05 | |
dc.description.abstract | (1) Background: The development of effective COVID-19 vaccines has reduced the impact of COVID-19 on the general population. Our study aims to analyze how vaccination modifies the likelihood of death and length of stay in hospitalized patients with COVID-19; (2) Methods: A retrospective cohort study of 1927 hospitalized patients infected with COVID-19 was conducted. Information was gathered on vaccination status, hospitalization episode, and clinical profile of the patients. The effect of vaccination on mortality was analyzed using a multiple logistic regression model, and length of stay was analyzed using linear regression. The performance and fit of the models were evaluated; (3) Results: In hospitalized patients with COVID-19, the risk of dying during admission in vaccinated patients was half that of non-vaccinated (OR: 0.45; CI 95%: 0.25 to 0.84). In patients who were discharged due to improvement, the reduction in hospital stay in vaccinated patients was 3.17 days (CI 95%: 5.88 to 0.47); (4) Conclusions: Patients who, despite having been vaccinated, acquire the infection by SARS-CoV-2, have a significant reduction of the risk of death during admission and a reduction of hospital stay compared with unvaccinated patients. | |
dc.identifier.doi | 10.3390/jcm11133905 | |
dc.identifier.issn | 2077-0383 | |
dc.identifier.pmc | PMC9267443 | |
dc.identifier.pmid | 35807189 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267443/pdf | |
dc.identifier.unpaywallURL | https://www.mdpi.com/2077-0383/11/13/3905/pdf?version=1656992809 | |
dc.identifier.uri | http://hdl.handle.net/10668/21317 | |
dc.issue.number | 13 | |
dc.journal.title | Journal of clinical medicine | |
dc.journal.titleabbreviation | J Clin Med | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | 10 | |
dc.publisher | MDPI AG | |
dc.pubmedtype | Journal Article | |
dc.relation.publisherversion | https://www.mdpi.com/resolver?pii=jcm11133905 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | COVID-19 vaccines | |
dc.subject | critical care | |
dc.subject | hospital mortality | |
dc.subject | hospitalisation | |
dc.subject | vaccine effectiveness | |
dc.subject.decs | Modelos lineales | |
dc.subject.decs | Modelos logísticos | |
dc.subject.decs | SARS-CoV-2 | |
dc.subject.decs | Tiempo de internación | |
dc.subject.decs | Vacunación | |
dc.subject.decs | Vacunas contra la COVID-19 | |
dc.subject.decs | Hospitalización | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Length of Stay | |
dc.subject.mesh | Patient Discharge | |
dc.subject.mesh | COVID-19 Vaccines | |
dc.subject.mesh | SARS-CoV-2 | |
dc.subject.mesh | Logistic Models | |
dc.subject.mesh | Linear Models | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Hospitalization | |
dc.subject.mesh | Vaccination | |
dc.title | How Does Vaccination against SARS-CoV-2 Affect Hospitalized Patients with COVID-19? | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1